Search Results - "Gausman, Daria"

A Phase 2 Study of Nivolumab for Relapsed/Refractory Multiple Myeloma or Non-Hodgkin Lymphoma Following CAR-T Therapy by Banerjee, Rahul, Lynch, Ryan C, Wu, Qian, Simon, Sylvain, Ujjani, Chaitra S, Till, Brian G, Wuliji, Natalie, Gausman, Daria, Dizon, Joshua, Kwok, Mary L., Lee, Sarah S., Silbermann, Rebecca, Medvedova, Eva, Maloney, David G, Ramos, Jorge Daniel, Shadman, Mazyar, Gauthier, Jordan, Turtle, Cameron J., Gopal, Ajay K, Green, Damian J, Riddell, Stanley R., Cowan, Andrew J.

“…Background: Treatment options are limited for patients with relapsed multiple myeloma (MM) or non-Hodgkin lymphoma (NHL) after CAR-T failure. While checkpoint…”
Get full text

The impact of B‐cell‐directed therapy on SARS‐CoV‐2 vaccine efficacy in chronic lymphocytic leukaemia by Ujjani, Chaitra, Shadman, Mazyar, Lynch, Ryan C., Tu, Brian, Stevenson, Philip A., Grainger, Caitlin, Zhu, Haiying, Hill, Joshua A., Huang, Meei‐Li, Nielsen, Leslie, Poh, Christina, Sorensen, Tyler, Gopal, Ajay K., Warren, Edus H., Till, Brian G., Lee, Sydney, Gausman, Daria, Smith, Stephen D., Gooley, Ted, Greninger, Alex

“…Prior reports evaluating SARS‐CoV‐2 vaccine efficacy in chronic lymphocytic leukaemia (CLL) used semiquantitative measurements of anti‐S to evaluate immunity;…”
Get full text

Post-CAR-T Checkpoint Inhibition Can Result in Durable Responses in a Minority of Patients with Multiple Myeloma (MM) or Non-Hodgkin's Lymphoma (NHL): Results of a Phase 2 Study of Nivolumab after CAR-T Failure by Banerjee, Rahul, Lynch, Ryan C, Wu, Qian Vicky, Simon, Sylvain, Ujjani, Chaitra S, Till, Brian G, Wuliji, Natalie, Gausman, Daria, Dizon, Joshua, Kwok, Mary L., Lee, Sarah S., Silbermann, Rebecca W, Medvedova, Eva, Maloney, David G., Ramos, Jorge, Shadman, Mazyar, Gauthier, Jordan, Turtle, Cameron J., Gopal, Ajay K, Green, Damian J., Riddell, Stanley R., Cowan, Andrew J.

“…While checkpoint inhibition may theoretically improve T-cell effector function following CAR-T failure, a prospective trial of pembrolizumab following CAR-T in…”
Get full text